Middle East CF Association (MECFA): Impact Overview
The mission of the Middle East CF Association (MECFA) is to improve health outcomes and life expectancy of patients with Cystic fibrosis...
Middle East Hospitals Gain Access to Much Needed Cystic Fibrosis Diagnosis and Treatment Resources
Through the MECFA diagnostic pilot program, ten hospitals located throughout the Middle East can now provide early accurate cystic...
Study Will Assess How Diet, Exercise May Extend Lifespan
People with cystic fibrosis (CF) generally are living longer and healthier lives than in the recent past. Now, researchers will conduct a...
Lung Disease Evident in CF Patients in Study Despite ‘Normal’ Lung Function
Signs of lung disease were evident in most cystic fibrosis (CF) patients with normal lung function in a small study, and related with a...
Bioengineer to Use $2M Grant to Study Gene Editing for CF
A bioengineer at Rice University will use a more than $2 million federal grant for a project to “repair” harmful mutations that cause...
Krystal Biotech Provides Updates from its Rare Genetic Lung Disease Pipeline
New preclinical data from GLP toxicology and biodistribution study demonstrates in vivo safety of KB407 for cystic fibrosis Company...
Levels of Neutrophil Elastase May Help Predict Disease Severity in CF
Levels of neutrophil elastase, a pro-inflammatory enzyme normally released by immune cells known as neutrophils, plus a greater diversity...
AzurRx BioPharma's OPTION 2 Trial Of MS1819 In Cystic Fibrosis Fails, What Next?
(RTTNews) - AzurRx BioPharma Inc.'s (AZRX) phase IIb study of MS1819 for the treatment of exocrine pancreatic insufficiency in patients...
“Sweat Stickers” May Ease Cystic Fibrosis Diagnosis and Management
An elevated chloride concentration in an infant’s sweat is indicative of the genetic, progressive disease cystic fibrosis. Many current...
CHMP Favors Kaftrio to Treat CF Patients in EU Starting at Age 12
A European Medicines Agency (EMA) committee favors extending the label for Kaftrio (ivacaftor/tezacaftor/elexacaftor), in combination...
